Pricing Log in Create free account
Friday 6 November 2026 Export TMDX’s income statement to Excel — free account

TransMedics Group, Inc.

TMDX Healthcare Medical Devices

TransMedics Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $605.5 million, up 37.1% from fiscal 2024.

Revenue
+41.2%
EPS
−31.0%
Free cash flow
−55.4%
Total debt
−89.3%

Quarter to September 2026, against a year earlier

85.08 16.10 +23.34%
Market cap
$2.4B
P/E
16.4×
Fwd P/E
49.4×
Dividend yield
—
F-score
7/9
Altman Z
5.32
Beneish M
−1.32
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

TransMedics Group, Inc. (TMDX) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, TransMedics Group, Inc. (TMDX) trades at a EV/Sales of 3.8×. Over the past ten years it has ranged from 3.5× (May 2019) to 42.5× (March 2021); the current reading is higher than 1% of that period. That is above the Medical Devices industry median of 2.7× and above the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 6.9× 35.01%
FY2024 5.1× (52.91%)
FY2023 10.8× (34.72%)
FY2022 16.6× 6.15%
FY2021 15.6× (0.20%)
FY2020 15.6× 65.02%
FY2019 9.5× 169.68%
FY2018 3.5× 0.00%
FY2017 3.5× 0.00%
FY2016 3.5× —

Quarterly newest first

Period EV/Sales Change
Sep 2026 4.5× 12.83%
Jun 2026 4.0× (33.00%)
Mar 2026 6.0× (12.70%)
Dec 2025 6.9× 0.45%
31 more quarters

Against its own ten years

Low 3.5× High 42.5×
Ten-year median 12.7×
Current reading's percentile 1

EV/Sales against peers

Company EV/Sales
NVCR NovoCure Limited compare 1.8×
INSP Inspire Medical Systems, Inc. compare 1.8×
NEOG Neogen Corporation compare 3.6×
UFPT UFP Technologies, Inc. compare 3.7×
TMDX TransMedics Group, Inc. 3.8×
ESTA Establishment Labs Holdings Inc. compare 8.7×
AXGN AxoGen, Inc. compare 8.8×
BFLY Butterfly Network, Inc. compare 12.5×
ALMR Alamar Biosciences, Inc. compare 15.6×
Medical Devices industry median 2.7×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on TMDX